dc.contributor.author | Ince, Bahri | |
dc.contributor.author | Gedikbasi, Asuman | |
dc.contributor.author | Ozcan, Muhammed Emin | |
dc.contributor.author | Karadeli, Hasan Huseyin | |
dc.contributor.author | Asil, Talip | |
dc.contributor.author | Altinoz, Meric A. | |
dc.date.accessioned | 2021-03-06T11:48:02Z | |
dc.date.available | 2021-03-06T11:48:02Z | |
dc.identifier.citation | Ozcan M. E. , Ince B., Karadeli H. H. , Gedikbasi A., Asil T., Altinoz M. A. , "Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity", NEUROPSYCHIATRIC DISEASE AND TREATMENT, cilt.12, ss.2033-2038, 2016 | |
dc.identifier.issn | 1178-2021 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_f0cd59fb-e819-4623-bcec-99898bcb030d | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/158011 | |
dc.identifier.uri | https://doi.org/10.2147/ndt.s109954 | |
dc.description.abstract | Objective: To define whether minor adult hemoglobin A2 (HbA2, alpha 2 delta 2) exerts any protective activity in multiple sclerosis (MS). | |
dc.language.iso | eng | |
dc.subject | Nöroloji | |
dc.subject | Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Psikiyatri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity | |
dc.type | Makale | |
dc.relation.journal | NEUROPSYCHIATRIC DISEASE AND TREATMENT | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 12 | |
dc.identifier.startpage | 2033 | |
dc.identifier.endpage | 2038 | |
dc.contributor.firstauthorID | 228917 | |